Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies-March 2024-www.financetom.com

Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies

May 9, 2024 4:30 AM

May 9 (Reuters) - Metaphore Biotechnologies said on

Thursday it would collaborate with Novo Nordisk to

develop up to two therapies for obesity management.

(Reporting by Puyaan Singh in Benagluru; Editing by Anil

D'Silva)

Previous page： Lennar Closes Milrose Properties Spinoff Next page： Ascentage Pharma Says Underwriters Exercise Option to Buy Additional American Depositary Shares

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lennar Closes Milrose Properties Spinoff

Feb 7, 2025

09:27 AM EST, 02/07/2025 (MT Newswires) -- Lennar ( LEN ) said Friday it has closed the spinoff of Millrose Properties via a distribution of nearly 80% of Millrose's Class A and Class B common stock to Lennar's ( LEN ) shareholders as of Jan. 21. The Lennar ( LEN ) shareholders received one Millrose share for every two Lennar...

Ascentage Pharma Says Underwriters Exercise Option to Buy Additional American Depositary Shares

Feb 7, 2025

09:20 AM EST, 02/07/2025 (MT Newswires) -- Ascentage Pharma ( AAPG ) said Friday that underwriters of its US initial public offering have partially exercised an over-allotment option to buy an additional 935,144 American depositary shares at the IPO price of $17.25 per ADS. After the partial exercise of the over-allotment option, the total number of ADSs sold in the...

Accenture Reportedly Ending Global Diversity, Inclusion Goals

Feb 7, 2025

09:29 AM EST, 02/07/2025 (MT Newswires) -- Accenture ( ACN ) is discontinuing its global diversity and inclusion goals following an assessment of its internal policies and practices, as well as the US landscape, multiple media outlets reported Friday, citing an internal Accenture ( ACN ) memo sent by chief executive officer Julie Sweet. The company will begin to phase...

German packaging firm Gerresheimer exploring sale, Bloomberg News reports

Feb 7, 2025

Feb 7 (Reuters) - German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter. (Reporting by Devika Nair in Bengaluru; Editing by Devika Syamnath) ...